HIT to lead activities 1

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/12

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 6:59 AM on 9/18/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

13 Terms

1
New cards

what can happen if a drug is too lipophilic?

it will deposit into the fatty tissues/membrane and not partition out. also highly liphophillic drugs can have more off target side effects as binding is unselective

2
New cards

why is it important to test microsomal stability?

the liver will try to detoxify drugs to excrete them so this will reduce the concentration, so this assay measures compound clearance

3
New cards

what is Caco-2 permability

it is a model of membrane made up of epithelial mono layer, used to tested drug absorption in the gut

4
New cards

what is the target value for aqueous soluability?

below 100 micro molar

5
New cards

what is the target value for liphophilicy?

0-3

6
New cards

what is the target value for microsomal stability?

greater than 30 ul/min-1/mg-1

7
New cards

what is the target value for CYP450 inhibtion?

less than 10uM

8
New cards

what is the target value for Caco-2 permeability?

less than 1×10^-6cm-1

9
New cards

what is the target value for the MDR1MDCK permeability?

less than 10×10^-6

10
New cards

what can the MDR1MDCK permeability model be used to predict?

intestinal and brain permeability

11
New cards

what is the target value for hep g2 hepatotoxicity?

no effect at 50 times the concentration of IC50

12
New cards

what is the target value for cytotoxicity?

no effect at 50 times the concentration of IC50

13
New cards

when would you use template hopping and how does it work?

this can be used when an identified HIT compound has been patented by another company. the aim would be to keep pharmacophore but made changes to the structure that occupies a unique intellectual property (IP) space.